Eli Lilly Expands Its In Vivo Ambitions, Acquiring Cell Therapy Startup Orna for up to $2.4B – MedCity News
The next frontier for cell therapy is shaping up to be in vivo treatments for autoimmune disease, and Eli Lilly…
The next frontier for cell therapy is shaping up to be in vivo treatments for autoimmune disease, and Eli Lilly…
Amari Morton faced an impossible decision during his time as a student at Emory University. Pay for his therapy sessions or…
Sports software, gene therapy, landlord pet rules: NC’s top 10 startup deals of 2025 Raleigh News & Observer Source link